(Q65392585)
Statements
An Open-Label, Single-Arm Phase IIIb Study in Patients With Neovascular Age-Related Macular Degeneration or Macular Edema Secondary to Retinal Vein Occlusion to Evaluate the Usability of Lucentis® 0.5 mg Prefilled Syringe (English)
0 references
21 March 2016
0 references
5 April 2016
0 references
35
0 references
18 year
0 references